People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Other Technology, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Modern Meadow, Inc. | — | Other Technology | Series D+ | $186.6M | $3.8B | 2020 |
| PBS Biotech, Inc. | — | Biotechnology | Series B | $43.2M | $55.7M | 2022 |
| Kythera Biopharmaceuticals Inc | — | Pharmaceuticals | Series B | $37.4M | $1.3B | 2011 |
| Napo Pharmaceuticals Inc | — | Biotechnology | Seed | $10.1M | $6.1M | 2011 |
Dennis Fenton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dennis Fenton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Brian Lee | 1 | 19 |
| DAVID SHAW | 1 | 12 |
| Bart Swanson | 1 | 8 |
| David Schnell | 1 | 7 |
| Camille Samuels | 1 | 6 |
| Steven King | 1 | 6 |
| Pravin Chaturvedi | 1 | 4 |
| Joseph Turner | 1 | 4 |
| Richard Fields | 1 | 4 |
| Andras Forgacs | 1 | 4 |
| Joshua Mailman | 1 | 4 |
| Hironori Hozoji | 1 | 4 |
| Klaus Hommels | 1 | 4 |
| Daniel Friedman | 1 | 3 |
| Gabor Forgacs | 1 | 3 |
| Lisa Conte | 1 | 3 |
| Nathaniel David | 1 | 3 |
| Francois Kress | 1 | 3 |
| Bryan Poltilove | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.